ENTITY

Cellumed Co Ltd (049180 KS)

Analysis

Health Care • South Korea

Cellumed Co., Ltd. banks human tissue for transplanting and grafting, and manufactures medical implant devices. The Company banks bone, cartilaginous tissue, ligaments and tendons for allografting and manufactures bone growth factor, artificial joints, and spinal implants.

Refresh

Focused

No publications yet

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00